Morphine Sulfate
NDC Package 70166-101-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Morphine Sulfate is a medication used to treat severe pain. Marketed by Lohxa, this product is identified by NDC 70166-101 and is authorized under FDA application NDA201517.

Identification & Billing

NDC Package Code
70166-101-10
Package Description
30 BAG in 1 BOX / 1 SYRINGE, PLASTIC in 1 BAG / .5 mL in 1 SYRINGE, PLASTIC
Product Code
70166-101
11-Digit Billing Format
70166010110
RxNorm Crosswalk
  • RxCUI: 892625 - morphine sulfate 20 MG in 1 mL Concentrate for Oral Solution
  • RxCUI: 892625 - morphine sulfate 20 MG/ML Oral Solution
  • RxCUI: 892625 - morphine sulfate 10 MG per 0.5 ML Concentrate for Oral Solution
  • RxCUI: 892625 - morphine sulfate 100 MG per 5 ML Concentrate for Oral Solution
  • RxCUI: 892625 - morphine sulfate 20 MG/ML Concentrate for Oral Solution

Clinical Specifications

Proprietary Name
Morphine Sulfate
Dosage Form
-
Usage Information
This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Regulatory & Marketing

Labeler Name
Lohxa
FDA Application #
NDA201517
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-29-2018
Listing Expiration
12-31-2023
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70166-101). Click a package code to view its specific billing and regulatory data.

70166-101-02
30 BAG in 1 BOX / 1 SYRINGE, PLASTIC in 1 BAG / .125 mL in 1 SYRINGE, PLASTIC
70166-101-05
30 BAG in 1 BOX / 1 SYRINGE, PLASTIC in 1 BAG / .25 mL in 1 SYRINGE, PLASTIC
70166-101-20
30 BAG in 1 BOX / 1 SYRINGE, PLASTIC in 1 BAG / 1 mL in 1 SYRINGE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70166-101-10 identifies a specific commercial package of 30 bag in 1 box / 1 syringe, plastic in 1 bag / .5 ml in 1 syringe, plastic of Morphine Sulfate, labeled by Lohxa. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Lohxa on May 29, 2018. The current certification is valid through December 31, 2023.

What are the primary indications for this medication?

This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

How is this Lohxa product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70166010110. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70166-101-10
11-Digit CMS (5-4-2)
70166-0101-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.